Novel Plasma Proteomic Biomarkers for Early Identification of Induction Chemotherapy Beneficiaries in Locoregionally Advanced Nasopharyngeal Carcinoma

Novel Plasma Proteomic Biomarkers for Early Identification of Induction Chemotherapy Beneficiaries in Locoregionally Advanced Nasopharyngeal Carcinoma

BackgroundInduction chemotherapy (IC) can alleviate locoregionally advanced nasopharyngeal carcinoma (LA-NPC), but effectiveness differs between patients, toxicity is problematic, and effective blood-based IC efficacy predictors are lacking. Here, we aimed to identify biomarkers for early identifica...

Full description

Bibliographic Details
Main Authors: Shan-Qiang Zhang, Su-Ming Pan, Shu-Zhen Lai, Hui-Jing Situ, Jun Liu, Wen-Jie Dai, Si-Xian Liang, Li-Qing Zhou, Qi-Qi Lu, Pei-Feng Ke, Fan Zhang, Hai-Bin Chen, Ji-Cheng Li
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Oncology
Subjects:
nasopharyngeal carcinoma
induction chemotherapy
efficacy prediction
proteomics
biomarker identification
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.889516/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2022.889516/full

Similar Items